EE123 Cost-Effectiveness of the Brexu-Cel in Relapsed/Refractory Mantle Cell Lymphoma and B-Cell Acute Lymphoblastic Leukemia: A Systematic Review
Jun 1, 2024, 00:00 AM
10.1016/j.jval.2024.03.422
https://www.valueinhealthjournal.com/article/S1098-3015(24)00537-0/fulltext
Section Title :
Section Order :
11771
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(24)00537-0&doi=10.1016/j.jval.2024.03.422